Ameritas Investment Company’s AbbVie ABBV Stock Holding History

Ameritas Investment Company’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$2.28M	Buy	21,120 +12,769	+153%	+$1.46M	0.11%	157
2021 Q2	$2.36M	Sell	8,351 -4,157	-33%	-$468K	0.11%	153
2021 Q1	$1.35M	Buy	12,508 +6,090	+95%	+$651K	0.12%	176
2020 Q4	$686K	Sell	6,418 -127	-2%	-$12.2K	0.13%	167
2020 Q3	$643K	Hold	6,545	–	–	0.2%	133
2020 Q2	$643K	Sell	6,545 -2,399	-27%	-$211K	0.19%	137
2020 Q1	$667K	Buy	8,944 +356	+4%	+$30.3K	0.11%	156
2019 Q4	$760K	Buy	8,588 +3,828	+80%	+$318K	0.16%	127
2019 Q3	$374K	Buy	+4,760	New	+$326K	0.08%	229
2019 Q2	–	Sell	-8,049	Closed	-$649K	–	225
2019 Q1	$649K	Sell	8,049 -17,603	-69%	-$1.44M	0.12%	141
2018 Q4	$2.37M	Buy	+25,652	New	+$2.26M	0.51%	45

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameritas Investment Company's ABBV Position: Q3 2021 in Review

Ameritas Investment Company increased its AbbVie (ABBV) stake by 153% in Q3 2021, buying an estimated $1.46M and bringing the position to 21,120 shares worth $2.28M. The position accounts for 0.11% of the portfolio, ranked #157.

Ameritas Investment Company first reported a position in ABBV in Q4 2018 and has held it in 11 quarters since. The position peaked at $2.37M in Q4 2018. 2,655 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

Ameritas Investment Company held 21,120 shares of AbbVie worth $2.28M as of Q3 2021.
Ameritas Investment Company bought 12,769 AbbVie shares in Q3 2021, an estimated $1.46M.
AbbVie made up 0.11% of Ameritas Investment Company's portfolio in Q3 2021, its #157 holding.
Ameritas Investment Company first reported a position in AbbVie in Q4 2018 and has held it in 11 quarters since.
Ameritas Investment Company's AbbVie position peaked at $2.37M in Q4 2018.
2,655 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on Ameritas Investment Company's 13F filing for Q3 2021, filed 12 Nov 2021.